» Articles » PMID: 33953671

Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma

Overview
Journal Front Pharmacol
Date 2021 May 6
PMID 33953671
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Cough variant asthma (CVA), a common asthma phenotype characterized by nonproductive cough and bronchial hyperreactivity (BHR), is usually detected by bronchial provocation tests (BPTs) which are timeconsuming, expensive, and unsafe. The primary study objective was to provide proof of concept for the use of fractional exhaled nitric oxide (FNO), eosinophil count percentage in induced sputum (sEOS%), forced expiratory flow between 25 and 75% of forced vital capacity (FEF) % predicted value, and FEF z-scores as surrogate markers predicting BHR in young adults with suspected CVA; the secondary objective was to compare the diagnostic performance of the various techniques. Three hundred and ten subjects (median age 24 years) were included in a cross-sectional study. Subjects were characterized as BHR positive (POS) ( = 147) or BHR negative (NEG) (n = 163) according to methacholine BPT. Classification accuracies were expressed as areas under the receiver operator characteristic curves (AUC). Compared with BHR NEG, FEF % predicted value and FEF z-scores were lower in the BHR POS group ( < 0.001), whereas FNO ( < 0.001) and sEOS% were higher ( < 0.001). AUC values for detecting BHR were as follows: FNO, 0.98 (SD = 0.02); sEOS%, 0.98 (SD = 0.02); FEF % pred, 0.93 (SD = 0.05); FEF z scores, 0.92 (SD = 0.05). Optimal cutoff values (OCV) for BHR prediction were as follows: FNO, 32.7 ppb (sensitivity = 0.93, specificity = 0.96), sEOS%, 3.80% (sensitivity = 0.94, specificity = 0.94), FEF % predicted value, 80.0% (sensitivity = 0.90, specificity = 0.87), and FEF z-score, -0.87 (sensitivity = 0.89, specificity = 0.87). Non-invasive/semi-invasive airway inflammatory or small airway functional measures might be used as surrogate markers predicting BHR in young adults with suspected CVA.

Citing Articles

Correlation of neutrophil percentage-to-albumin ratio with lung function in American adults: a population study.

Zhang X, Bai F, Ni H, Chen S, Fu D, Ren H BMC Pulm Med. 2025; 25(1):86.

PMID: 39984929 PMC: 11846293. DOI: 10.1186/s12890-025-03537-9.


Diagnostic Accuracy of FEF for Bronchial Hyperresponsiveness in Patients with Suspected Asthma and/or Allergic Rhinitis: A Systematic Review and Meta-analysis.

Wang D, Liu C, Bao C, Hu J, Li Z, Ma X Lung. 2025; 203(1):23.

PMID: 39762581 DOI: 10.1007/s00408-024-00759-2.


Bibliometric Analysis of Cough Variant Asthma from 1993 to 2022.

Zhu Z, Wu J, Chen W, Luo F, Zhao X J Asthma Allergy. 2024; 17:517-537.

PMID: 38855058 PMC: 11162189. DOI: 10.2147/JAA.S452097.


Correlation analysis between serum total IgE and FeNO and idiosyncratic reaction in bronchiolitis.

Xu X, Han W, Han W Clinics (Sao Paulo). 2024; 79:100384.

PMID: 38754226 PMC: 11126779. DOI: 10.1016/j.clinsp.2024.100384.


Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases.

Ragnoli B, Radaeli A, Pochetti P, Kette S, Morjaria J, Malerba M Ther Adv Chronic Dis. 2023; 14:20406223231190480.

PMID: 37538344 PMC: 10395178. DOI: 10.1177/20406223231190480.


References
1.
ElHalawani S, Ly N, Mahon R, Amundson D . Exhaled nitric oxide as a predictor of exercise-induced bronchoconstriction. Chest. 2003; 124(2):639-43. DOI: 10.1378/chest.124.2.639. View

2.
Coates A, Wanger J, Cockcroft D, Culver B, Diamant Z, Gauvreau G . ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017; 49(5). DOI: 10.1183/13993003.01526-2016. View

3.
Maniscalco M, Faraone S, Sofia M, Molino A, Vatrella A, Zedda A . Extended analysis of exhaled and nasal nitric oxide for the evaluation of chronic cough. Respir Med. 2015; 109(8):970-4. DOI: 10.1016/j.rmed.2015.05.016. View

4.
McFadden Jr E, Linden D . A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med. 1972; 52(6):725-37. DOI: 10.1016/0002-9343(72)90078-2. View

5.
van der Wiel E, Ten Hacken N, Postma D, van den Berge M . Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review. J Allergy Clin Immunol. 2013; 131(3):646-57. DOI: 10.1016/j.jaci.2012.12.1567. View